La cadena de opciones muestra datos clave de las opciones de acciones de Inspire Veterinary a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Inspire Veterinary..

Inspire Veterinary (NASDAQ:IVP) Bolsa, Cadena de Opciones

Inspire Veterinary

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Inspire Veterinary Partners, Inc. - Class A Common Stock

Inspire Veterinary Partners Inc

IVANHOE MINES LTD A by Ivanhoe Mines Ltd.

Ivanhoe Mines Ltd

Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) reported quarterly losses of $(0.45) per share. This is a 62.5 percent increase over losses of $(1.20) per share from the same period last year. The company reported $1.00 million in sales this quarter. This is a 70.49 percent decrease over sales of $3.39 million the same period last year.

Earnings

News

Kidpik Q3 EPS $(0.45) Up From $(1.20) YoY, Sales $1.00M Down From $3.39M YoY

TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate.

TMC Metals Q3 2024 GAAP EPS $(0.06), Inline

HCW Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) reported $426.42 thousand in sales this quarter. This is a 50.02 percent decrease over sales of $853.10 thousand the same period last year.

HCWB

HCW Biologics Q3 Sales $426.42K Down From $853.10K YoY

AGFY

Agrify Q3 EPS $(17.31) Up From $(19.02) YoY; Revenue $1.934M Down From $3.139M YoY

Trading Ideas

BRK/A

POOL

SIRI

Berkshire Hathaway 13F Shows Added New Stake In Sirius XM Holdings With 105.16M Shares, Worth $2.49B; Added New Stake In Domino's Pizza With 1.28M Shares, Worth $549.4M; Added New Stake In Pool Corp With 404,057 Shares, Worth $152.2M

Berkshire Hathaway 13F Shows Increased Stake In American Express By 17% To 151.6M Shares, Now Worth $41.1B; Increased Stake In Kroger By 15% To 50M Shares, Worth $2.87B; Increased Stake In DaVita By 18%, Now Valued At $5.92B; Increased Stake In Moody's Corp By 13% To 24.67M Shares, Now Worth $11.71B

ROLR

High Roller Technologies Unaudited Q3 Revenue $7.52M Up From $5.80M QoQ

Telsey Advisory Group analyst Dana Telsey maintains European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) with a Outperform and maintains $8 price target.

Price Target

Analyst Ratings

EWCZ

Telsey Advisory Group Maintains Outperform on European Wax Center, Maintains $8 Price Target

CHTR

Berkshire Hathaway 13F Shows Reduced Stake In Bank Of America By 23% To 797.7M Shares, Worth $31.7B; Reduced Stake In Charter Communications By 26% To 2.82M Shares, Worth $914.5M; Reduced Stake In Nu Holdings By 19% To 86.4M Shares, Worth $1.18B; Reduced Stake In Occidental Petroleum By 18%, Now Valued At $13.16B

Consolidated Water Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.25 by 24 percent. The company reported quarterly sales of $33.391 million which beat the analyst consensus estimate of $31.750 million by 5.17 percent. This is a 33.02 percent decrease over sales of $49.854 million the same period last year.

Earnings Beats

CWCO

Consolidated Water Co Q3 2024 GAAP EPS $0.31 Beats $0.25 Estimate, Sales $33.391M Beat $31.750M Estimate

NMHI

Nature's Miracle Holding Q3 EPS $(0.09), Sales $3.05M Up From $2.69M YoY

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) with a Buy and maintains $9 price target.

KAPA

D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

<a href="https://truthsocial.com/@realDonaldTrump/113483513301208163" title="https://truthsocial.com/@realDonaldTrump/113483513301208163">https://truthsocial.com/@realDonaldTrump/113483513301208163</a>

Macro Notification

Politics

General

CORRECTION: Trump Picks Jay Clayton For U.S. Attorney For The Southern District Of New York

Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares are up 23.4% to $89.54 in November following the company's <a href="https://www.benzinga.com/news/earnings/24/11/41754359/astera-labs-stock-is-ripping-higher-today-whats-going-on">impressive third-quarter earnings</a> beat Wall Street expectations, reinforcing its role as a critical player in AI infrastructure. 
What To Know: Astera reported earnings of 23 cents per share, exceeding the estimated 17 cents, alongside revenue of $113.1 million, up 206% year-over-year and well above analyst forecasts of $97.4 million. 
CEO Jitendra Mohan highlighted that the company achieved its fifth consecutive quarter of record-breaking revenue, with sales rising 47% from the previous quarter, driven by new growth in AI connectivity solutions.
Astera's latest product, the Scorpio Smart Fabric Switch, is central to its strategy. These switches are designed to enhance data transfer speeds between GPUs, CPUs and storage devices, addressing critical needs in AI data centers where performance demands are skyrocketing.
Read Also: <a href="https://www.benzinga.com/tech/24/11/41973572/ray-dalios-bridgewater-cuts-stake-in-microsoft-stock-by-20-is-big-tech-losing-its-shine">Ray Dalio&#8217;s Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?</a>
What Else: The company's strong performance and promising product pipeline prompted multiple analysts to raise their price targets.
JPMorgan increased its target to $110 per share, while Deutsche Bank, Barclays and others <a href="https://www.benzinga.com/quote/ALAB/analyst-ratings">made upward revisions</a>. 
Astera's revenue forecast for the fourth quarter of $126–$130 million, alongside expected earnings of 25 cents to 26 cents per share, has added momentum to investor enthusiasm.
Read Also: <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a>
<h2 class="wp-block-heading">How To Buy ALAB Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Astera Labs&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ALAB has a 52-week high of $100.09 and a 52-week low of $36.22.

ALAB

Astera Labs (ALAB) Stock Is Up 23% This Month: What's Going On?

CV Sciences, Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTCQB">CVSI</a>), a <a href="http://benzinga.com/topic/hemp">hemp</a>-focused wellness company, announced stable revenue in its Q3 2024 financials on Thursday. The company generated $3.9 million in revenue, a slight decline from $4.1 million in Q3 2023, yet maintained a gross margin of 46%, up from 45.1% the previous year.
<h4 class="wp-block-heading">Q3 2024 Financial Highlights</h4>
<ul>
<li>Revenue: $3.9 million, a 5% decline from $4.1 million in Q3 2023 and stable compared to <a href="https://www.benzinga.com/markets/cannabis/24/08/40344002/hemp-focused-cv-sciences-reports-flat-revenue-and-over-8-yoy-increase-in-gross-profit-in-q2">$4 million in Q2 2024</a>.</li>
<li>Net loss: $456,000, slightly higher than the $447,000 loss in Q3 2023.</li>
<li>Adjusted EBITDA: Loss of $75,000, significantly improved from a loss of $361,000 in Q3 2023.</li>
<li>Gross profit: $1.78 million, a slight decrease from $1.84 million in Q3 2023, reflecting an improved gross margin of 46%, up from 45.1% in the same period last year.</li>
</ul>
<h3 class="wp-block-heading">New Product Lines Boost Growth</h3>
Operating with a cash balance of $1 million, CV Sciences recorded an adjusted EBITDA loss of $75,000, <a href="https://www.benzinga.com/markets/cannabis/24/03/37988133/hemp-focused-wellness-co-moves-closer-to-profitability-reports-flat-2023-revenue-increase-in-gro">inching closer</a> to cash flow break-even.
Furthermore, the company's recent launches, including the cannabinoid-free +PlusHLTH supplement line, target cognitive health, stress relief and metabolism support. Additionally, CV Sciences expanded its pet health segment with hip, joint and calming chews, aiming to capture a broader consumer base.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Management Commentary</h3>
CEO Joseph Dowling highlighted the <a href="https://www.benzinga.com/markets/cannabis/24/08/40344002/hemp-focused-cv-sciences-reports-flat-revenue-and-over-8-yoy-increase-in-gross-profit-in-q2">steady core revenue</a> in a challenging environment, noting new products and acquisitions as positioning factors for growth in 2025. &#8220;Our third quarter 2024 progress demonstrates our continuous commitment to innovation and cost-efficient execution as we move closer to profitability and positive cash flow,&#8221; Dowling <a href="https://www.prnewswire.com/news-releases/cv-sciences-inc-reports-third-quarter-2024-financial-results-302305079.html">said</a> in a press release.
Read Also: <a href="https://www.benzinga.com/24/11/41971875/cbd-pioneer-charlottes-web-narrows-loss-in-q3-focuses-on-long-term-growth-amid-challenging-cannabis-industry-environment">CBD Pioneer Charlotte&#8217;s Web Narrows Loss In Q3, Focuses On Long-Term Growth</a>
"We look forward to organically grow our business and pursue additional M&amp;A opportunities in the near future to improve our top-line revenue, profitability and shareholder value," he added.
<h3 class="wp-block-heading">CV Sciences Holds Top Market Spot</h3>
In Q3, CV Sciences further solidified its market position, maintaining top-seller status in the natural products retail channel, according to SPINS data. The company also secured $0.9 million in financing from Streeterville, aimed at fueling operational and product expansion.
CVSI Price Action CVSI's shares were trading 7.73% lower at $0.04235 per share at the time of this writing around 12:35 PM ET Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41974843/cbd-pharma-co-medipharm-37-increase-in-q3-international-sales-15-yoy-revenue-growth">CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth</a></li>
</ul>

Cannabis

CVSI

CV Sciences Q3: Revenue Stable Amid New Launches, Financing

RIVN

iShares Trust Barclays 20+ Year Treasury Bond Fund

Soros Fund Management 13F Shows Exited Position In SPDR S&P 500 ETF, Previously Holding 450,000 Shares; Exited Stake In Rivian Automotive Call Options, Previously Holding 5,450,000 Shares; Exited Put Position In Ishares 20+ Year Treasury Bond ETF, Previously Holding 360,000 Shares; Exited Stake In Westrock Co, Previously Holding 3,342,953 Shares;  Exited Stake In Livongo Health Convertible Notes, Previously Holding $45M In Principal

PMNT

Perfect Moment Q2 EPS $(0.17) Up From $(0.29) YoY; Revenue $3.833M Down From $5.888M YoY

Canaccord Genuity analyst Joseph Vafi maintains Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) with a Buy and raises the price target from $22 to $32.

Canaccord Genuity Maintains Buy on Hut 8, Raises Price Target to $32

PXLW

Pixelworks Enters $10M "At-The-Market" Equity Offering Agreement With Roth Capital, Allowing Periodic Common Stock Sales With 2.5% Commission; Roth To Act As Sales Agent

GOOGL

LBRDA

Soros Fund Management 13F Shows Decreased Stake In Rivian Automotive Convertible Notes By 21% To $155.9M In Principal; Decreased Stake In Wayfair Convertible Notes By 11% To $119.5M In Principal; Decreased Stake In Liberty Broadband Corp By 19% To 1,119,893 Shares; Decreased Stake In Alphabet Class A By 43% To 517,890 Shares; Decreased Put Position In Ishares IBoxx High Yield Corporate Bond ETF By 40% To 1,500,000 Shares

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Inspire Veterinary&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>)&nbsp;stock is falling on Thursday following the <a href="https://www.nasdaq.com/press-release/inspire-veterinary-partners-announces-closing-6-million-public-offering-2024-07-10">closing of a public offering</a> for the veterinary hospital company&rsquo;s shares.



Inspire Veterinary completed a $6 million public offering for its shares yesterday. That saw the company sell 6 million shares of IVP stock at a price of $1 per share. It also offered pre-funded warrants for investors whose beneficial ownership would exceed 4.99%.



Inspire Veterinary also outlined its plans for the funds raised from this public offering. The company intends to use the money for &ldquo;working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).&rdquo;



<h2>What This Means for IVP Stock</h2>



A public offering increases the total number of outstanding shares that a company has. This also dilutes the stakes of current investors in the business. This is one of the reasons why IVP stock is falling on Thursday.



The price of the shares in the public offering was also well below the closing price of IVP stock. This is likely another reason why the company&rsquo;s shares are losing ground today.



IVP stock is down 25% as of Thursday morning. However, the company&rsquo;s shares also saw a 110.2% rally on Wednesday.



Investors will want to stick around for even more of the most recent stock market stories today!



We have all of the hottest stock market news worth reading about on Thursday! A few examples include what&rsquo;s happening with shares of Volcon&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) and Blue Star Foods&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bsfc-stock-quote/">BSFC</a>) stock, as well as the biggest pre-market stock movers this morning. All of this info is ready at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-volcon-vlcn-stock-up-85-today/">Why Is Volcon (VLCN) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-blue-star-foods-bsfc-stock-up-74-today/">Why Is Blue Star Foods (BSFC) Stock Up 74% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-11th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-inspire-veterinary-ivp-stock-down-25-today/">Why Is Inspire Veterinary (IVP) Stock Down 25% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Inspire Veterinary (IVP) Stock Down 25% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Quhuo&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/qh-stock-quote/">QH</a>) stock is sliding lower on Thursday after the gig economy platform company&rsquo;s shares underwent a recent rally.



That rally saw shares of QH stock close out Wednesday up 24.7%. That came alongside more than 2 million shares traded. To put that number in perspective, the company&rsquo;s daily average trading volume is below that at 183,000 shares. Its <a href="https://finance.yahoo.com/quote/QH/key-statistics/">float is 44.47 million units</a>.



Investors will note that QH stock rallied on Wednesday without any news from the company. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There also wasn&rsquo;t any analyst coverage behind the surge in price and trading.



<h2>QH Stock Movement on Thursday</h2>



Considering yesterday&rsquo;s rally happened without a clear catalyst, it makes sense that shares of QH stock would give up some of their gains. This has Quhuo&nbsp;stock down 10.5% during pre-market trading on Thursday morning.



This dip in price comes without much in the way of trading activity today. As of this writing, only about 10,000 shares of QH stock have been traded.



It&rsquo;s also worth noting that QH shares aren&rsquo;t performing well in 2024. The company&rsquo;s stock is down 63.3% year-to-date as of yesterday&rsquo;s close. It&rsquo;s also down 72.7% over the last 12 months.



Investors seeking out even more of the most recent stock market stories today will want to stick around!



We have all of the hottest stock market news that investors need to know about on Thursday! That includes all of the hottest market happenings for Inspire Veterinary&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) stock, Volcon&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) shares and Blue Star Foods&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bsfc-stock-quote/">BSFC</a>) stock. You can catch up on all of these matters at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-inspire-veterinary-ivp-stock-down-25-today/">Why Is Inspire Veterinary (IVP) Stock Down 25% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-volcon-vlcn-stock-up-85-today/">Why Is Volcon (VLCN) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-blue-star-foods-bsfc-stock-up-74-today/">Why Is Blue Star Foods (BSFC) Stock Up 74% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-quhuo-qh-stock-down-10-today/">Why Is Quhuo (QH) Stock Down 10% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Quhuo (QH) Stock Down 10% Today?

An update from Inspire Veterinary Partners, Inc. Class A (IVP) is now available. Kimball Carr's tenure as Chief Executive Officer has been extended...

Inspire Veterinary Partners CEO Tenure Extended, New Steering Committee Formed

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Inspire Veterinary (NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) just reported results for the second quarter of 2024.<ul><li>Inspire Veterinary reported earnings per share of -70 cents.</li><li>The company reported revenue of $4.39 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ivp-stock-earnings-inspire-veterinary-for-q2-of-2024/">IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024

Inspire Veterinary Partners GAAP EPS of -$0.70, revenue of $4.4M

Inspire Veterinary Partners to acquire Vetsie.ai

Inspire Veterinary Partners files $100M mixed shelf offering

Inspire Veterinary stock higher as it looks to raise $2.5M through direct offering

Inspire Veterinary (IVP) Partners has entered into a securities purchase agreement with institutional investors, providing for the purchase and sal...

Inspire Veterinary to sell 10M shares at 25c in registered direct offering

Inspire Veterinary Partners GAAP EPS of -$0.38, revenue of $4.05M

BSFC

VLCN

Screenshot 2024-02-27 at 6.34.08 PM

Emerging Markets

Markets

CHWY

FRPT

More Millennials Are Opting For Pets Over Children As Pet Industry Continues To Grow

Events

Press Releases

Inspire Veterinary Partners to Present at Sidoti Virtual Investor Conference August 14

Inspire Veterinary Partners Reaffirms Plans to Accelerate Acquisition and Growth Strategy Following Closing of Recent Public Offering

Inspire Veterinary Partners Reports Second Quarter 2024 Financial Results

Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

Inspire Veterinary Partners Unveils Plans for New Verticals to Drive Next Phase of Growth in Veterinary Care

Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

Inspire Veterinary Partners Announces $2.5 Million Registered Direct Offering of Common Stock

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

Comments

Inspire Veterinary

Inspire Veterinary (IVP) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL